SDLogi

What SDLogi does

S.D.Logi CO., LTD. (株式会社エス・ディ・ロジ) is a Japanese healthcare logistics provider founded in 1958 and headquartered in Nagoya, Aichi Prefecture. The company operates as a wholly-owned subsidiary of Suzuken Co., Ltd. (株式会社スズケン), one of Japan's largest pharmaceutical wholesale groups, and serves as the group's dedicated logistics arm spanning the full pharmaceutical supply chain.

The company's core platform consists of eight integrated service modules: (1) logistics center operations for the Suzuken Group's wholesale distribution network, (2) pharmaceutical warehousing with handheld-terminal-based inventory management, (3) pharmaceutical delivery via a fleet of 1,678 owned vehicles (144 refrigerated), (4) in-hospital SPD (Supply Processing and Distribution) services that offload non-core logistics tasks from pharmacists, (5) manufacturer logistics for 49 pharmaceutical manufacturers, including GDP-compliant temperature-controlled storage at 10 dedicated centers, (6) clinical trial drug delivery in partnership with S.D.Collabo, (7) regenerative medicine handling with liquid nitrogen-based ultra-low temperature storage, and (8) licensed pharmaceutical and regenerative medicine product manufacturing. Underlying technology is rooted in physical cold-chain infrastructure (ambient, refrigerated, controlled-temperature, and cryogenic storage using liquid nitrogen), GDP/PIC/S-aligned quality management systems with ISO9001:2015 certification across 26 locations, and BCP capabilities including 72-hour continuous power generation at the Miyagi facility.

The business model is contract-based B2B logistics under long-term agreements. Revenue is generated through service fees from pharmaceutical manufacturers, the Suzuken Group's wholesale distribution entities, healthcare institutions (for SPD), and dispensing pharmacies. FY2025 revenue was ¥46.8 billion across 4,728 employees. Distribution is purely direct (no intermediaries), spanning all major regions of Japan (Hokkaido, Tohoku, Kanto, Chubu, Tokai, Kansai, Kyushu) via 153 wholesale branches and 12 manufacturer logistics centers. Pricing is contractually negotiated and not publicly disclosed. The company has no external funding events as a wholly-owned subsidiary.

Name

SDLogi

Legal name

株式会社エス・ディ・ロジ (S.D.Logi CO., LTD.)

Website

https://sdlogi.com

Company type

Private

Founded year

1958

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

SDLogi is a wholly-owned subsidiary of Suzuken Co., Ltd. providing end-to-end pharmaceutical logistics in Japan, including GDP-compliant cold-chain distribution, manufacturer logistics, in-hospital SPD services, clinical trial drug delivery, and regenerative medicine handling across 153 wholesale branches and 12 manufacturer logistics centers.

Ownership category

akta.pro rank

Product category

Pharmaceutical Logistics Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Refrigerated Warehousing and Storage (493120)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Pharmaceutical & Biopharma Cold Chain Logistics (2–8°C, CRT, GDP) (TLAIAIAA)

akta.pro secondary industries

Pharmaceutical & Life Sciences Warehousing (GDP-Compliant) (TLAIACAD), Clinical Trial Logistics & Depot Services (IRT-integrated, kitting, returns) (HLAGAMAC), Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD)

Keywords

• Pharmaceutical logistics services
• Healthcare cold chain
• Hospital SPD services
• Clinical trial drug delivery
• Regenerative medicine logistics

Headquarters

HQ city

Nagoya

HQ country

Japan

HQ region

Asia

Offices15 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Logistics Services: S.D.Logi generates revenue through contracted B2B logistics services including pharmaceutical distribution/delivery, warehouse operations, logistics center management, hospital in-house logistics (SPD), clinical trial drug delivery, and pharmaceutical manufacturing. Revenue is derived from service fees charged to pharmaceutical manufacturers, group companies, and healthcare institutions under long-term contractual arrangements. The company reported sales of ¥46,800,000,000 for fiscal year 2025.
2. Pharmaceutical Manufacturing Operations: Revenue from pharmaceutical and regenerative medicine product manufacturing operations at licensed manufacturing facilities in East and West Japan. Manufacturing services include packaging, labeling, and storage of pre-shipment judgment pharmaceuticals, with one-stop logistics from manufacturing through delivery to medical institutions and patients.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

S.D.Logi operates an integrated pharmaceutical logistics platform providing logistics center management, pharmaceutical warehousing, temperature-controlled delivery, hospital in-house (SPD) logistics, manufacturer logistics, clinical trial drug delivery, regenerative medicine handling with liquid nitrogen cryogenic storage, and licensed pharmaceutical/regenerative medicine product manufacturing. Services span the entire pharmaceutical supply chain from manufacturer to dispensing pharmacy and patient, under GDP-aligned quality management and ISO9001:2015 certification across 26 facilities. The company serves 49 pharmaceutical manufacturers, the Suzuken Group wholesale network of 153 branches, and 25 medical institutions under direct B2B contract arrangements.

Product overview

SDLogi operates as a unified healthcare logistics platform offering eight integrated service modules covering the entire pharmaceutical supply chain. The core portfolio includes logistics center management, pharmaceutical warehousing, and delivery services for route and urgent shipments. Hospital logistics (SPD) services support in-facility operations, while manufacturer logistics provides pharmaceutical makers with GDP-compliant temperature-controlled distribution. Specialized offerings include clinical trial drug delivery with refrigerated vehicles and regenerative medicine handling with ultra-low temperature storage. The manufacturing division holds permits for both pharmaceutical and regenerative medicine products, enabling one-stop logistics from pre-shipment storage through final delivery to medical institutions and patients. The company manages 12 manufacturer logistics centers, 26 ISO9001-certified locations, and serves 49 contracted manufacturers across Japan.

Differentiator

Problem solved

Functional benefit

Products and services

• Logistics Center Business (物流センター事業) National logistics center operations handling inbound, outbound, and inventory management with advanced material handling equipment to ensure reliability, speed, safety, and productivity in pharmaceutical distribution for the Suzuken Group network.
• Pharmaceutical Warehouse Business (医薬品倉庫事業) Warehouse operations including inbound processing, outbound picking, and location management using handheld terminals for accurate handling of pharmaceuticals, diagnostic agents, medical devices, and supplies from logistics centers and manufacturers.
• Pharmaceutical Delivery Business (医薬品配送事業) Route delivery to designated accounts (hospitals, clinics, pharmacies) and urgent deliveries, including outbound inspection, delivery confirmation through face-to-face verification, and return/recall product collection services.
• Hospital In-House Logistics (SPD) Business (病院内物流（SPD）事業) Supply Processing and Distribution services that reduce pharmacists' non-core workload by handling drug stacking, picking, and inventory checks, allowing pharmacists to focus on core duties while maintaining optimal inventory levels at 25 contracted medical facilities nationwide.
• Manufacturer Logistics Business (メーカー物流事業) High-quality logistics services for pharmaceutical manufacturers including strict temperature management (ambient, refrigerated, controlled temperature), GDP-compliant quality management, facility management, and education/training, operating across 10 manufacturer logistics centers and serving 49 contracted manufacturers.
• Clinical Trial Drug Delivery Business (治験薬配送事業)

Quantifiable outcome

• Successfully deployed SPD (Supply Processing and Distribution) at 25 healthcare facilities nationwide, enabling pharmacists to focus on clinical duties and contributing to reduced pharmaceutical inventory costs.
• +4 more outcomes

Named customers8 records

Segments6 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• 株式会社エス・ディ・コラボ (S.D.Collabo Co., Ltd.)coreStrategic or Co-development Partner · 1 April 2010S.D.Collabo was established to support joint logistics initiatives within the pharmaceutical industry. S.D.Logi partners with S.D.Collabo for clinical trial drug delivery operations (since April 2010) and jointly operates a regenerative medicine platform. S.D.Collabo provides manufacturer support for pharmaceutical industry logistics co-localization initiatives.
• 株式会社スズケン (Suzen Co., Ltd.)coreStrategic or Co-development PartnerSuzen Co., Ltd. is the 100% parent company (完全親会社) of S.D.Logi. S.D.Logi operates as the group's core logistics subsidiary, managing all pharmaceutical logistics operations for the Suzen Group including manufacturer logistics, wholesale logistics, hospital in-house logistics (SPD), and clinical trial drug delivery. The group reported consolidated sales of ¥2,486.6 billion in FY2025. The relationship is integral to S.D.Logi's business foundation, providing the customer base, brand, and contractual framework for logistics operations.
• 一般財団法人日本科学技術連盟 (JUSE — Japanese Union of Scientists and Engineers)minorOthersJUSE awarded S.D.Logi the Japan Quality Incentive Award TQM Practice Award in 2025. JUSE also conducts ISO9001:2015 certification audits for the company's logistics centers through its certification services.
• GMP/PIC/S GDP Regulatory Framework PartnersminorOthersS.D.Logi's operations comply with GMP (Good Manufacturing Practice), PIC/S (Pharmaceutical Inspection Co-operation Scheme), and GDP (Good Distribution Practice) guidelines, which involve adherence to international pharmaceutical quality standards and regulatory frameworks. These are not commercial partnerships but regulatory compliance frameworks.

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Senko Group Holdings Co., Ltd. Major Japanese logistics provider with pharma/healthcare distribution capabilities and existing partnership with SDLogi (operates West Kobe Logistics Center). Overlaps in pharmaceutical distribution though broader across industries.
• DHL Supply Chain (Life Sciences): Global 3PL with dedicated Life Sciences & Healthcare division offering GDP-compliant warehousing, cold chain, and clinical trial logistics. Comparable to SDLogi's integrated pharma logistics platform though at global scale.
• Nippon Express Co., Ltd. Japan's largest logistics company with a dedicated pharmaceutical/life sciences division offering cold chain distribution. Comparable to SDLogi in pharma logistics but operates across many industries at much larger scale.
• Kuehne+Nagel International AG: Global logistics incumbent operating a dedicated pharma & healthcare vertical with cold chain, GDP compliance, and clinical trial capabilities. Comparable in pharma logistics sophistication though serving global rather than purely Japanese customers.

Direct peers

• Toho Holdings Co., Ltd. Pharmaceutical wholesaler with comprehensive distribution network across Japan. Comparable to SDLogi's parent Suzuken in pharma wholesale and logistics services, including manufacturer-facing operations.
• Medipal Holdings Corporation: Major Japanese pharmaceutical wholesaler with integrated logistics operations. Most directly comparable as a Japan-headquartered pharma wholesaler with distribution scale similar to the Suzuken Group that owns SDLogi.
• Alfresa Holdings Corporation: One of Japan's largest pharmaceutical wholesalers with national distribution and manufacturer logistics services. Directly comparable to SDLogi's parent Suzuken in operating model, scale, and pharma logistics offering.
• Suzuken Co., Ltd. Parent company of SDLogi and Japan's major pharmaceutical wholesaler with ¥2.5T consolidated revenue. Closest comparable in operating model since SDLogi essentially runs Suzuken's logistics; useful for understanding the captive customer base.

Emerging players

• Solasto Corporation: Japanese medical services company providing hospital support services including SPD (Supply Processing and Distribution). Directly comparable to SDLogi's SPD hospital in-house logistics business.
• World Courier (Cencora): Specialty courier focused on clinical trial drug logistics and pharmaceutical cold chain for global biopharma. Comparable to SDLogi's clinical trial drug delivery and regenerative medicine handling businesses.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SDLogi